Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 32

1.

Erratum for Rhee et al., "Pharmacokinetics, Safety, and Tolerability of Single and Multiple Doses of Relebactam, a β-Lactamase Inhibitor, in Combination with Imipenem and Cilastatin in Healthy Participants".

Rhee EG, Rizk ML, Calder N, Nefliu M, Warrington SJ, Schwartz MS, Mangin E, Boundy K, Bhagunde P, Colon-Gonzalez F, Jumes P, Liu Y, Butterton JR.

Antimicrob Agents Chemother. 2018 Nov 26;62(12). pii: e02197-18. doi: 10.1128/AAC.02197-18. Print 2018 Dec. No abstract available.

2.

Pharmacokinetics, Safety, and Tolerability of Single and Multiple Doses of Relebactam, a β-Lactamase Inhibitor, in Combination with Imipenem and Cilastatin in Healthy Participants.

Rhee EG, Rizk ML, Calder N, Nefliu M, Warrington SJ, Schwartz MS, Mangin E, Boundy K, Bhagunde P, Colon-Gonzalez F, Jumes P, Liu Y, Butterton JR.

Antimicrob Agents Chemother. 2018 Aug 27;62(9). pii: e00280-18. doi: 10.1128/AAC.00280-18. Print 2018 Sep. Erratum in: Antimicrob Agents Chemother. 2018 Nov 26;62(12):.

3.

Incidence and prevalence of NMOSD in Australia and New Zealand.

Bukhari W, Prain KM, Waters P, Woodhall M, O'Gorman CM, Clarke L, Silvestrini RA, Bundell CS, Abernethy D, Bhuta S, Blum S, Boggild M, Boundy K, Brew BJ, Brown M, Brownlee WJ, Butzkueven H, Carroll WM, Chen C, Coulthard A, Dale RC, Das C, Dear K, Fabis-Pedrini MJ, Fulcher D, Gillis D, Hawke S, Heard R, Henderson APD, Heshmat S, Hodgkinson S, Jimenez-Sanchez S, Killpatrick T, King J, Kneebone C, Kornberg AJ, Lechner-Scott J, Lin MW, Lynch C, Macdonell R, Mason DF, McCombe PA, Pender MP, Pereira JA, Pollard JD, Reddel SW, Shaw C, Spies J, Stankovich J, Sutton I, Vucic S, Walsh M, Wong RC, Yiu EM, Barnett MH, Kermode AG, Marriott MP, Parratt JDE, Slee M, Taylor BV, Willoughby E, Wilson RJ, Vincent A, Broadley SA.

J Neurol Neurosurg Psychiatry. 2017 Aug;88(8):632-638. doi: 10.1136/jnnp-2016-314839. Epub 2017 May 26.

4.

Mortality in Mild Cognitive Impairment: A Longitudinal Study in Memory Clinics.

Connors MH, Ames D, Boundy K, Clarnette R, Kurrle S, Mander A, Ward J, Woodward M, Brodaty H.

J Alzheimers Dis. 2016 Jul 27;54(1):149-55. doi: 10.3233/JAD-160148.

PMID:
27472874
5.

CCNF mutations in amyotrophic lateral sclerosis and frontotemporal dementia.

Williams KL, Topp S, Yang S, Smith B, Fifita JA, Warraich ST, Zhang KY, Farrawell N, Vance C, Hu X, Chesi A, Leblond CS, Lee A, Rayner SL, Sundaramoorthy V, Dobson-Stone C, Molloy MP, van Blitterswijk M, Dickson DW, Petersen RC, Graff-Radford NR, Boeve BF, Murray ME, Pottier C, Don E, Winnick C, McCann EP, Hogan A, Daoud H, Levert A, Dion PA, Mitsui J, Ishiura H, Takahashi Y, Goto J, Kost J, Gellera C, Gkazi AS, Miller J, Stockton J, Brooks WS, Boundy K, Polak M, Muñoz-Blanco JL, Esteban-Pérez J, Rábano A, Hardiman O, Morrison KE, Ticozzi N, Silani V, de Belleroche J, Glass JD, Kwok JB, Guillemin GJ, Chung RS, Tsuji S, Brown RH Jr, García-Redondo A, Rademakers R, Landers JE, Gitler AD, Rouleau GA, Cole NJ, Yerbury JJ, Atkin JD, Shaw CE, Nicholson GA, Blair IP.

Nat Commun. 2016 Apr 15;7:11253. doi: 10.1038/ncomms11253.

6.

Predictors of Mortality in Dementia: The PRIME Study.

Connors MH, Ames D, Boundy K, Clarnette R, Kurrle S, Mander A, Ward J, Woodward M, Brodaty H.

J Alzheimers Dis. 2016 Apr 12;52(3):967-74. doi: 10.3233/JAD-150946.

PMID:
27079702
7.

A patient with progressive dyspnea and multiple foci of airspace consolidation.

Boundy KE, Fraire AE, Oliveira PJ.

Chest. 2014 Jan;145(1):167-172. doi: 10.1378/chest.13-0122. No abstract available.

PMID:
24394829
8.

Among vitamin B12 deficient older people, high folate levels are associated with worse cognitive function: combined data from three cohorts.

Moore EM, Ames D, Mander AG, Carne RP, Brodaty H, Woodward MC, Boundy K, Ellis KA, Bush AI, Faux NG, Martins RN, Masters CL, Rowe CC, Szoeke C, Watters DA.

J Alzheimers Dis. 2014;39(3):661-8. doi: 10.3233/JAD-131265.

PMID:
24246419
9.

Prevalence and predictors of burden in caregivers of people with dementia.

Brodaty H, Woodward M, Boundy K, Ames D, Balshaw R; PRIME Study Group.

Am J Geriatr Psychiatry. 2014 Aug;22(8):756-65. doi: 10.1016/j.jagp.2013.05.004. Epub 2013 Sep 5.

PMID:
24012226
10.

Increased risk of cognitive impairment in patients with diabetes is associated with metformin.

Moore EM, Mander AG, Ames D, Kotowicz MA, Carne RP, Brodaty H, Woodward M, Boundy K, Ellis KA, Bush AI, Faux NG, Martins R, Szoeke C, Rowe C, Watters DA; AIBL Investigators.

Diabetes Care. 2013 Oct;36(10):2981-7. doi: 10.2337/dc13-0229. Epub 2013 Sep 5. Erratum in: Diabetes Care. 2013 Nov;36(11):3850.

11.

Patients in Australian Memory Clinics: baseline characteristics and predictors of decline at six months.

Brodaty H, Woodward M, Boundy K, Ames D, Balshaw R; PRIME Study Group.

Int Psychogeriatr. 2011 Sep;23(7):1086-96. doi: 10.1017/S1041610211000688. Epub 2011 Apr 14.

PMID:
21489344
12.

Does executive impairment define a frontal variant of Alzheimer's disease?

Woodward M, Brodaty H, Boundy K, Ames D, Blanch G, Balshaw R; PRIME Study Group.

Int Psychogeriatr. 2010 Dec;22(8):1280-90. doi: 10.1017/S1041610210001596. Epub 2010 Aug 19.

PMID:
20719041
13.

The long-term efficacy and tolerability of donepezil in patients with vascular dementia.

Wilkinson D, Róman G, Salloway S, Hecker J, Boundy K, Kumar D, Posner H, Schindler R.

Int J Geriatr Psychiatry. 2010 Mar;25(3):305-13. doi: 10.1002/gps.2340.

PMID:
19623601
14.

Mild autonomic dysfunction in primary Sjögren's syndrome: a controlled study.

Cai FZ, Lester S, Lu T, Keen H, Boundy K, Proudman SM, Tonkin A, Rischmueller M.

Arthritis Res Ther. 2008;10(2):R31. doi: 10.1186/ar2385. Epub 2008 Mar 7.

15.

Naturalistic treatment of Alzheimer's disease with galantamine: 12-month follow-up from the NATURE study.

Brodaty H, Woodward M, Boundy K, Barnes N.

CNS Drugs. 2007;21(4):335-6. No abstract available.

PMID:
17381186
16.

A naturalistic study of galantamine for Alzheimer's disease.

Brodaty H, Woodward M, Boundy K, Barnes N, Allen G; NATURE Investigators.

CNS Drugs. 2006;20(11):935-43.

PMID:
17044730
17.

Reduced posterior cingulate binding of I-123 iodo-dexetimide to muscarinic receptors in mild Alzheimer's disease.

Boundy KL, Barnden LR, Katsifis AG, Rowe CC.

J Clin Neurosci. 2005 May;12(4):421-5.

PMID:
15925773
18.

Association of a negative residual stenosis following rescue/adjunctive percutaneous coronary intervention with impaired myocardial perfusion and adverse outcomes among ST-segment elevation myocardial infarction patients.

Gibson CM, Kirtane AJ, Boundy K, Ly H, Karmpaliotis D, Murphy SA, Giugliano RP, Cannon CP, Antman EM, Braunwald E; TIMI Study Group.

J Am Coll Cardiol. 2005 Feb 1;45(3):357-62.

19.

Association of epicardial and tissue-level reperfusion with left ventricular end-diastolic pressures in ST-elevation myocardial infarction.

Kirtane AJ, Bui A, Murphy SA, Karmpaliotis D, Kosmidou I, Boundy K, Rahman A, Pinto DS, Aroesty JM, Giugliano RP, Cannon CP, Antman EM, Gibson CM; TIMI Study Group.

J Thromb Thrombolysis. 2004 Jun;17(3):177-84.

PMID:
15353915
20.

Pharmacological treatment of cognitive deficits in Alzheimer's disease.

Brodaty H, Ames D, Boundy KL, Hecker J, Snowdon J, Storey E, Yates MW.

Med J Aust. 2001 Sep 17;175(6):324-9. Review.

PMID:
11665948
21.

Localization of temporal lobe epileptic foci with iodine-123 iododexetimide cholinergic neuroreceptor single-photon emission computed tomography.

Boundy KL, Rowe CC, Black AB, Kitchener MI, Barnden LR, Sebben R, Kneebone A, Kassiou M, Katsifis A, Lambrecht R.

Neurology. 1996 Oct;47(4):1015-20.

PMID:
8857738
22.

The dexamethasone suppression test and the diagnosis of depression in adults with severe and profound developmental disabilities.

Mudford OC, Barrera FJ, Murray A, Boundy K, Caldwell K, Goldberg B.

J Intellect Disabil Res. 1995 Aug;39 ( Pt 4):275-83.

PMID:
7579985
23.

Human dosimetry and biodistribution of iodine-123-iododexetimide: a SPECT imaging agent for cholinergic muscarinic neuroreceptors.

Boundy KL, Barnden LR, Rowe CC, Reid M, Kassiou M, Katsifis AG, Lambrecht RM.

J Nucl Med. 1995 Jul;36(7):1332-8.

24.

Therapeutic shock device (TSD): clinical evaluation with self-injurious behaviors.

Mudford OC, Boundy K, Murray AD.

Res Dev Disabil. 1995 Jul-Aug;16(4):253-67.

PMID:
7480955
25.

A mutation in the alpha tropomyosin gene TPM3 associated with autosomal dominant nemaline myopathy NEM1.

Laing NG, Wilton SD, Akkari PA, Dorosz S, Boundy K, Kneebone C, Blumbergs P, White S, Watkins H, Love DR, et al.

Nat Genet. 1995 Jun;10(2):249. No abstract available.

PMID:
7663526
26.

A mutation in the alpha tropomyosin gene TPM3 associated with autosomal dominant nemaline myopathy.

Laing NG, Wilton SD, Akkari PA, Dorosz S, Boundy K, Kneebone C, Blumbergs P, White S, Watkins H, Love DR, et al.

Nat Genet. 1995 Jan;9(1):75-9. Erratum in: Nat Genet. 1995 Jun;10(2):249.

PMID:
7704029
27.

Inclusion body myositis in association with rheumatoid arthritis.

Soden M, Boundy K, Burrow D, Blumbergs P, Ahern M.

J Rheumatol. 1994 Feb;21(2):344-6.

PMID:
8182647
28.

Magnetic resonance imaging in carotid dissection.

Nelson JR, Boundy KL.

Australas Radiol. 1992 Feb;36(1):40-3.

PMID:
1632746
29.

Interoperator variability in quantitative electroencephalography.

Hamilton-Bruce MA, Boundy KL, Purdie GH.

Clin Exp Neurol. 1991;28:219-24.

PMID:
1821830
30.

Human adipocyte lipid-binding protein: purification of the protein and cloning of its complementary DNA.

Baxa CA, Sha RS, Buelt MK, Smith AJ, Matarese V, Chinander LL, Boundy KL, Bernlohr DA.

Biochemistry. 1989 Oct 31;28(22):8683-90.

PMID:
2481498
31.

Extra-adrenal phaeochromocytoma: report of three interesting cases.

Frewin DB, Jamieson GG, Russell WJ, Chatterton BE, Ropiha C, Boundy KL, Jonsson JR.

Aust N Z J Surg. 1989 Sep;59(9):691-5.

PMID:
2783092
32.

Syphilitic aneurysm of the right subclavian artery presenting with hemoptysis.

Boundy K, Bignold LP.

Aust N Z J Med. 1987 Oct;17(5):533-5.

PMID:
3446166

Supplemental Content

Loading ...
Support Center